Diabetes Clinical Trials in Massachusetts

Showing 581-600 of 610 trials

Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)

NCT00642174

This trial is designed as a phase 2 randomized, double-blind double dummy, active comparator controlled, two-period two-arm crossover study to enroll 40 patients across multiple centers. The study will compare platelet function following a prasugrel loading dose and 1 week of prasugrel maintenance therapy with high-dose clopidogrel loading dose and 1 week of high-dose clopidogrel maintenance therapy in patients with drug treated type 2 diabetes mellitus who have coronary artery disease. Various assays of platelet function will be used in this study. Platelet function will be studied using the following assays: Accumetrics VerifyNowTM P2Y12, Light Transmittance Aggregometry (LTA), Vasodilator-associated stimulated phosphoprotein (VASP), and Thromboelastography (TEG)-platelet mapping.

Diabetes MellitusCoronary Artery Disease

Eli Lilly and Company35 participantsStarted Apr 2008

Jacksonville, Florida, United States • Worcester, Massachusetts, United States • New York, New York, United States +1 more locations

COMPLETEDPhase 318 miles

Improving Diabetes Care for African Americans

NCT00436176

The goal of this study is to investigate methods of improving diabetes care for African Americans in primary care clinics. Primary care clinicians will receive training in the delivery of cross-cultural medicine as well as regular performance feedback reports.

Diabetes

Harvard Vanguard Medical Associates6,000 participantsStarted Jun 2007

Newton, Massachusetts, United States

Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)

Improving Diabetes Care for African Americans

Diabetes Trials in Other Cities

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD

Diabetes Control and Complications Trial (DCCT)

Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety

Effect of Immediate Hemoglobin A1c on Glycemic Control in Children With Type I Diabetes Mellitus

Self Monitoring of Blood Glucose With Finger Tip vs. Alternate Site Sampling: Effect on Long Term Glycemic Control

PPAR-COMBO With Sulfonylurea

Obese Patients With Type 2 Diabetes

Mitiglinide in Combination With Metformin vs. Metformin Alone in Patients With Type 2 Diabetes Mellitus

Study Evaluating Rimonabant Efficacy in Insulin-Treated Diabetic Patients(ARPEGGIO)

GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate

A Study to Evaluate NBI-6024 in Adult and Adolescent Patients With New Onset of Type 1 Diabetes Mellitus

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)

Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes

Effects of Metformin Hydrochloride (HCl) in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus and the Effects of Colesevelam HCl on Lipids and Glucose on Pre-diabetic Patients.

Pharmacokinetic Study of Vildagliptin in Patients With Renal Impairment

Pancreas Allotransplantation for Diabetic Nephropathy and Mild Chronic REnal fAilure Stage Study

Mechanism of Action and Efficacy of Muraglitazar in Type 2 Diabetes

AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes

Other Conditions in Massachusetts